The antitumor effect of trabectedin (TR) is potentiated by olaparib (OL) in preclinical models of bone and soft tissue sarcomas (STS).

被引：0
|
作者：
Pignochino, Ymera [1 ]
Capozzi, Federica [2 ]
Dell'aglio, Carmine [2 ]
Basirico, Marco [2 ]
D'ambrosio, Lorenzo [2 ]
Galizia, Danilo [2 ]
Palesandro, Erica [2 ]
Benassi, Maria Serena [3 ]
Aglietta, Massimo [2 ]
Grignani, Giovanni [4 ]
机构：
[1] Univ Turin, Fdn Piemonte Oncol, Candiolo, Italy
[2] Univ Turin, Candiolo, Italy
[3] Ist Ortoped Rizzoli, Bologna, Italy
[4] FPO, Candiolo, Italy
来源：
CANCER RESEARCH | 2013年 / 73卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2013-LB-213
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB213
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Pneumothorax occurrence in bone and soft tissue sarcomas: Incidence, prevalence, effect on mortality
    Horan, TA
    Berraldo, PS
    Santiago, FF
    CHEST, 2003, 124 (04) : 196S - 196S
  • [22] Effect of Tissue Inhomogeneity in Soft Tissue Sarcomas: From Real Cases to Numerical and Experimental Models
    Campana, Luca Giovanni
    Bullo, Marco
    Di Barba, Paolo
    Dughiero, Fabrizio
    Forzan, Michele
    Mognaschi, Maria Evelina
    Sgarbossa, Paolo
    Tosi, Anna Lisa
    Bernardis, Alessia
    Sieni, Elisabetta
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2018, 17
  • [23] Immune-checkpoint genes as predictive biomarkers of trabectedin in advanced soft-tissue sarcoma (STS): A Spanish Group for Research on Sarcomas (GEIS) translational study.
    Silva Moura, David
    Hindi, Nadia
    Lopez-Alvarez, Maria
    Sanchez-Bustos, Paloma
    Carrasco-Garcia, Irene
    Santos-Fernandez, Paloma
    Martinez-Delgado, Paula
    Lacerenza, Serena
    Blanco-Alcaina, Elena
    Lucinio Mondaza-Hernandez, Jose
    Gutierrez, Antonio
    Maria Alvarez, Rosa
    Cordeiro, Magda
    De Sande Gonzalez, Luis Miguel
    Marquina, Gloria
    Maria Cano, Juana
    Cruz Jurado, Josefina
    Valverde Morales, Claudia Maria
    Martinez-Trufero, Javier
    Martin Broto, Javier
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [24] Assessment of clinical benefit of cancer drugs recommended in National Comprehensive Cancer Network (NCCN) guidelines for advanced soft tissue sarcomas (STS) and bone sarcomas (BS)
    Aguado Sorolla, M.
    Teres Lleida, R.
    Piedra, A.
    Cardozo, A. R.
    Bosma, F.
    Cerda Serda, P.
    Lopez Pousa, A.
    Tibau, A.
    Sebio Garcia, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S1041 - S1041
  • [25] Patient-derived xenograft (PDX) models of soft tissue sarcoma (STS): a preclinical plafform for early drug testing
    Wozniak, Agnieszka
    Cornillie, Jasmien
    Gebreyohannes, Yemarshet K.
    Boeckx, Bram
    Li, Haifu
    Van Looy, Thomas
    Floris, Giuseppe
    Wellens, Jasmien
    Vreys, Lise
    Hompes, Daphne
    Stas, Marguerite
    Sinnaeve, Friedl
    Lambrechts, Diether
    Debiec-Rychter, Maria
    Sciot, Raf
    Schoffski, Patrick
    CANCER RESEARCH, 2016, 76
  • [26] HIGH-DOSE DTIC IN ADVANCED SOFT-TISSUE SARCOMAS (STS) OF THE ADULT - A PHASE-II STUDY OF THE EORTC SOFT-TISSUE AND BONE SARCOMA GROUP
    BUESA, JM
    MOURIDSEN, H
    VANOOSTEROM, AT
    STEWARD, WT
    VERWEY, J
    THOMAS, D
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (01) : 73 - 73
  • [27] Olaratumab Exerts Antitumor Activity in Preclinical Models of Pediatric Bone and Soft Tissue Tumors through Inhibition of Platelet-Derived Growth Factor Receptor α
    Lowery, Caitlin D.
    Blosser, Wayne
    Dowless, Michele
    Knoche, Shelby
    Stephens, Jennifer
    Li, Huiling
    Surguladze, David
    Loizos, Nick
    Luffer-Atlas, Debra
    Oakley, Gerard J., III
    Guo, Qianxu
    Iyer, Seema
    Rubin, Brian P.
    Stancato, Louis
    CLINICAL CANCER RESEARCH, 2018, 24 (04) : 847 - 857
  • [28] Antitumor effect of CSF-1/CSF-1R blockade in soft-tissue sarcomas
    Kondo, Ayana
    Fujiwara, Tomohiro
    Yoshida, Aki
    Hata, Toshiaki
    Kondo, Hiroya
    Ozaki, Toshifumi
    CANCER SCIENCE, 2023, 114 : 264 - 264
  • [29] Antitumor effect of CSF-1/CSF-1R blockade in soft-tissue sarcomas
    Kondo, Ayana
    Fujiwara, Tomohiro
    Yoshida, Aki
    Hata, Toshiaki
    Kondo, Hiroya
    Kunisada, Toshiyuki
    Ozaki, Toshifumi
    CANCER SCIENCE, 2023, 114 : 1247 - 1247
  • [30] Pharmacokinetic study of trabectedin administered as 24-hour infusion in elderly patients with advanced soft tissue sarcoma (STS) treated according to the TR1US ISG study
    Ferrari, M.
    Grosso, F.
    Grignani, G.
    Ibrahim, T.
    Tamberi, S.
    Marra, D.
    Marchesi, E.
    Porcu, L.
    D'Incalci, M.
    Zucchetti, M.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S63 - S63
12345